Aortenklappe: wann konservativ, wann operativ, wann interventionell?

Aortenklappenvitien gehören zu den häufigsten erworbenen Herzklappen-Erkrankungen. Der chirurgische Aortenklappen-Ersatz und ein konservatives Vorgehen waren lange die einzigen Therapien. Inzwischen stehen Katheter-basierte Klappenprothesen zur Verfügung, die zunehmend auch bei jüngeren Patienten mit geringerem OP-Risiko eingesetzt werden. Dieser Artikel gibt einen Überblick über die Therapieoptionen und die Wahl der optimalen Therapieform.

Abstract

Aortic valve disease, especially aortic valve stenosis, is one of the most common acquired valve diseases and is associated with increased mortality and morbidity. Due to the rising age of the population, the prevalence of aortic valve stenosis has increased sharply in recent years. For many years, surgical aortic valve replacement was the only available therapy beside the conservative approach. With the implantation of the first catheter-based valve prosthesis in 2002, the era of transcatheter aortic valve implantation began. While this therapy was initially limited to inoperable and high-risk patients, the indication has been increasingly extended to younger patients with lower surgical risk over the past years. However, choosing the optimal therapy modality and determining the ideal timing of treatment can often be challenging in clinical practice. The aim of this article is to provide an overview of the different therapy modalities, the decision-making process and current therapy guidelines.

Schlüsselwörter

Aortenklappen-Stenose - Aortenklappen-Insuffizienz - Transkatheter-Aortenklappen-Implantation - chirurgischer Aortenklappen-Ersatz

Key words

aortic valve stenosis - aortic valve regurgitation - transcatheter aortic valve implantation - surgical aortic valve replacement

Publication History

Article published online:
15 August 2022

• Literatur

• 1 Yadgir S, Johnson CO, Aboyans V. et al. Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017. Circulation 2020; 1670-1680
• 2 Cribier A. Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description. Circulation 2002; 106: 3006-3008 DOI: 10.1161/01.CIR.0000047200.36165.B8.
• 3 Deutscher Herzbericht 2020. Frankfurt am Main: Deutsche Herzstiftung; 2020 Im Internet (Stand: 05.06.2022): https://www.herzstiftung.de/system/files/2021-06/Deutscher-Herzbericht-2020.pdf
• 4 Leon MB, Smith CR, Mack M. et al. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. N Engl J Med 2010; 363: 1597-1607 DOI: 10.1056/NEJMoa1008232.
• 5 Smith CR, Leon MB, Mack MJ. et al. Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients. N Engl J Med 2011; 364: 2187-2198 DOI: 10.1056/NEJMoa1103510.
• 6 Leon MB, Smith CR, Mack MJ. et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 2016; 374: 1609-1620 DOI: 10.1056/NEJMoa1514616.
• 7 Reardon MJ, Van Mieghem NM, Popma JJ. et al. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 2017; 376: 1321-1331 DOI: 10.1056/NEJMoa1700456.
• 8 Mack MJ, Leon MB, Thourani VH. et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med 2019; 380: 1695-1705 DOI: 10.1056/NEJMoa1814052.
• 9 Popma JJ, Deeb GM, Yakubov SJ. et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med 2019; 380: 1706-1715 DOI: 10.1056/NEJMoa1816885.
• 10 Clavel M-A, Magne J, Pibarot P. Low-gradient aortic stenosis. Eur Heart J 2016; 37: 2645-2657 DOI: 10.1093/eurheartj/ehw096.
• 11 Vahanian A, Beyersdorf F, Praz F. et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022; 43: 561-632 DOI: 10.1093/eurheartj/ehab395.
• 12 Banovic M, Putnik S, Penicka M. et al. Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: The AVATAR Trial. Circulation 2022; 145: 648-658 DOI: 10.1161/circulationaha.121.057639.
• 13 Strange G, Stewart S, Celermajer D. et al. Poor Long-Term Survival in Patients With Moderate Aortic Stenosis. J Am Coll Cardiol 2019; 74: 1851-1863 DOI: 10.1016/j.jacc.2019.08.004.
• 14 Pibarot P, Weissman NJ, Stewart WJ. et al. Incidence and Sequelae of Prosthesis-Patient Mismatch in Transcatheter Versus Surgical Valve Replacement in High-Risk Patients With Severe Aortic Stenosis: A PARTNER Trial Cohort-A Analysis. J Am Coll Cardiol 2014; 64: 1323-1334 DOI: 10.1016/J.JACC.2014.06.1195.
• 15 Bourguignon T, Bouquiaux-Stablo AL, Candolfi P. et al. Very long-term outcomes of the carpentier-edwards perimount valve in aortic position. Ann Thorac Surg 2015; 99: 831-837 DOI: 10.1016/j.athoracsur.2014.09.030.
• 16 Adams DH, Popma JJ, Reardon MJ. et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis. N Engl J Med 2014; 370: 1790-1798 DOI: 10.1056/NEJMoa1400590.
• 17 Pibarot P, Ternacle J, Jaber WA. et al. Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial. J Am Coll Cardiol 2020; 76: 1830-1843 DOI: 10.1016/j.jacc.2020.08.049.
• 18 Makkar RR, Yoon SH, Chakravarty T. et al. Association between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke among Patients at Low Surgical Risk. JAMA – J Am Med Assoc 2021; 326: 1034-1044 DOI: 10.1001/jama.2021.13346.
• 19 Dall’Ara G, Tumscitz C, Grotti S. et al. Contemporary balloon aortic valvuloplasty: Changing indications and refined technique. Catheter Cardiovasc Interv 2021; 97: E1033-E1042 DOI: 10.1002/ccd.28807.
• 20 Singh JP, Evans JC, Levy D. et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (The Framingham Heart Study). Am J Cardiol 1999; 83: 897-902 DOI: 10.1016/S0002-9149(98)01064-9.